Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 5/2001

01-10-2001 | Commentary

Is succinylcholine appropriate or obsolete in the intensive care unit?

Author: Leo HDJ Booij

Published in: Critical Care | Issue 5/2001

Login to get access

Abstract

Muscle relaxants in intensive care unit (ICU) patients are predominantly administered to facilitate intubation. The adverse effect profile of succinylcholine is such that its use in the ICU must be considered obsolete. Suitable alternatives are the intermediately long-acting nondepolarizing relaxants, of which rocuronium is probably preferable.
Literature
1.
Heckmatt JZ, Pitt MC, Kirkham F: Peripheral neuropathy and neuromuscular blockade presenting as prolonged respiratory paralysis following critical illness. Neuropediatrics 1993, 24: 123-125.CrossRefPubMed
2.
Barohn RJ, Jackson CE, Rogers SJ, Ridings LW, McVey AL: Prolonged paralysis due to nondepolarising neuromuscular blocking agents and corticosteroids. Muscle Nerve 1994, 17: 647-654.CrossRefPubMed
3.
Fiacchino F, Gemma M, Bricchi M, Giombini S, Regi B: Sensitivity to curare in patients with upper and lower motor neurone dysfunction. Anaesthesia 1991, 46: 980-982.CrossRefPubMed
4.
Yentis SM: Suxamethonium and hyperkalaemia. Anaesth Intensive Care 1990, 18: 92-101.PubMed
5.
Martyn JAJ, White DA, Gronert GA, Jaffe RS, Ward JM: Up-and down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers. Anesthesiology 1992, 72: 822-843.
6.
Schwartz DE, Kelly B, Caldwell JE, Carlisle AS, Cohen NH: Succinylcholine-induced hyperkalemic arrest in a patient with severe metabolic acidosis and exsanguinating hemorrhage. Anesth Analg 1992, 75: 291-293.CrossRefPubMed
7.
Kindler GH, Verotta D, Gray AT, Gropper MA, Yost CS: Additive inhibition of nicotinic acetylcholine receptors by corticosteroids and the neuromuscular blocking drug vecuronium. Anesthesiology 2000, 92: 821-832. 10.1097/00000542-200003000-00026CrossRefPubMed
8.
Gronert GA: Cardiac arrest after succinylcholine. Mortality greater with rhabdomyolysis than receptor upregulation. Anesthesiology 2001, 94: 523-529. 10.1097/00000542-200103000-00026CrossRefPubMed
9.
Shearer ES, Russell GN: The effect of cardiopulmonary bypass on cholinesterase activity. Anaesthesia 1993, 48: 293-296.CrossRefPubMed
10.
Collard CD, Baker BW II, Johnson D, Bressler R, Harati Y: Cumulative reduction in serum cholinesterase following repeated therapeutic plasma exchange. J Clin Anesth 1996, 8: 44-48. 10.1016/0952-8180(95)00172-7CrossRefPubMed
11.
Robson N, Robertson I, Whittaker M: Plasma cholinesterase changes in the puerperium. Anaesthesia 1986, 41: 243-249.CrossRefPubMed
12.
Blanloeil Y, Delaroche O, Tequi B, Gunst JP, Dixneuf B: Prolonged apnea after suxamethonium administration during staphylococcal toxic shock [in French]. Ann Fr Anesth Reanim 1996, 15: 189-191. 10.1016/0750-7658(96)85041-6CrossRefPubMed
13.
Vanlinthout LEH, van Egmond J, De Boo T, Lerou JGC, Wevers RA, Booij LHDJ: Factors affecting magnitude and time course of neuromuscular block produced by suxamethonium. Br J Anaesth 1992, 69: 29-35.CrossRefPubMed
14.
Jensen ES, Viby-Mogensen J: Plasma cholinesterase and abnormal reaction to succinylcholine: twenty years experience with the Danish Cholinesterase research Unit. Acta Anaesthesiol Scand 1995, 39: 151-156.CrossRef
15.
Kelly RE, Dinner M, Turner LS, Haik B, Abramson DH, Daines P: Succinylcholine increased intraocular pressure in the human eye with the extraocular muscles detached. Anesthesiology 1993, 79: 948-952.CrossRefPubMed
16.
Flynn PJ, Goldhill DR: Hemodynamic effects of neuromusuclar blocking agents. J Cardiothorac Anesth 1990, 4: 31-37.CrossRef
17.
Kopman AF, Klewicka MM, Kopman DJ, Neuman GG: Molar potency is predictive of the speed of onset of neuromuscular block for agents of intemediate, short, and ultrashort duration. Anesthesiology 1999, 90: 425-431. 10.1097/00000542-199902000-00016CrossRefPubMed
18.
Ostergaard D, Jensen FS, Jensen E, Viby-Mogensen J: Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade. Acta Anaesth Scand 1989, 33(suppl 191): 164.
Metadata
Title
Is succinylcholine appropriate or obsolete in the intensive care unit?
Author
Leo HDJ Booij
Publication date
01-10-2001
Publisher
BioMed Central
Published in
Critical Care / Issue 5/2001
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc1039

Other articles of this Issue 5/2001

Critical Care 5/2001 Go to the issue

Research

Plasma colloid osmotic pressure in healthy infants

Review

Rational use of computerized protocols in the intensive care unit

Commentary

Paper reports overview: Restrictive transfusions, experienced radiologists and prone positioning

Research

Utility of routine chest radiographs in a medical–surgical intensive care unit: a quality assurance survey

Commentary

Cost effectiveness in treating ventilator-associated pneumonia

Research

Predisposing factors for delirium in the surgical intensive care unit